Table 1.
Characteristics of the SARS-CoV-2 RNA-positive study population, including a retrospective cohort of 147 patients sampled during the first French epidemic wave (between March and April 2020) and 145 patients prospectively tested during the second French epidemic wave (between November and December 2020).
| Retrospective cohort of SARS-CoV-2 RNA-positive patients(N = 147) | Prospective cohort of SARS-CoV-2 RNA-positive patients(N = 145) | |
|---|---|---|
| Median age (min-max), year | 65 (19–95) | 60 (17–100) |
| % male gender (n/N) | 53.7% (79/147) | 36.6% (53/145) |
| Wards | ||
| Intensive care units [% (n/N)] | 6.8% (10/147) | 3.4% (5/145) |
| Geriatric wards [% (n/N)] | 34.7% (51/147) | 43.4% (63/145) |
| Medical wards [% (n/N)] | 8.2% (12/147) | 11.0% (16/145) |
| Outpatients [% (n/N)] | 29.3% (43/147) | 13.8% (20/145) |
| Healthcare workers [% (n/N)] | 13.6% (20/147) | 24.8% (36/145) |
| Other [% (n/N)] | 7.5% (11/147) | 3.4% (5/145) |